Skip to main content
. 2015 Dec 28;21(1):59–71. doi: 10.1634/theoncologist.2015-0246

Figure 2.

Figure 2.

Hematologic toxicity. The incidence of severe hematologic toxicity (typically neutropenia) remains low when gemcitabine is used alone (gray bubbles), but a significant dose-related effect arises when gemcitabine is combined with cisplatin (red bubbles). For studies in which an overall rate of hematologic toxicity was not provided, neutropenia was used as a surrogate marker.